HUT64756A - Process for the production of quinoxaline derivatives and of pharmaceutical compositions containing them - Google Patents
Process for the production of quinoxaline derivatives and of pharmaceutical compositions containing themInfo
- Publication number
- HUT64756A HUT64756A HU9301877A HU9301877A HUT64756A HU T64756 A HUT64756 A HU T64756A HU 9301877 A HU9301877 A HU 9301877A HU 9301877 A HU9301877 A HU 9301877A HU T64756 A HUT64756 A HU T64756A
- Authority
- HU
- Hungary
- Prior art keywords
- production
- pharmaceutical compositions
- compositions containing
- quinoxaline derivatives
- quinoxaline
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4135871A DE4135871A1 (en) | 1991-10-26 | 1991-10-26 | New quinoxaline derivs. |
| DE4224200 | 1992-07-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9301877D0 HU9301877D0 (en) | 1993-09-28 |
| HUT64756A true HUT64756A (en) | 1994-02-28 |
Family
ID=25908683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9301877A HUT64756A (en) | 1991-10-26 | 1992-10-25 | Process for the production of quinoxaline derivatives and of pharmaceutical compositions containing them |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0565683A1 (en) |
| JP (1) | JP3258008B2 (en) |
| KR (1) | KR100262371B1 (en) |
| CN (1) | CN1038840C (en) |
| AU (1) | AU664212B2 (en) |
| CA (1) | CA2099270A1 (en) |
| CZ (1) | CZ286351B6 (en) |
| FI (1) | FI932959A (en) |
| HU (1) | HUT64756A (en) |
| IL (1) | IL103538A (en) |
| NO (1) | NO304693B1 (en) |
| NZ (1) | NZ244896A (en) |
| PL (1) | PL171125B1 (en) |
| PT (1) | PT101004B (en) |
| RU (1) | RU2117663C1 (en) |
| SK (1) | SK281518B6 (en) |
| WO (1) | WO1993008173A1 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK162491D0 (en) * | 1991-09-20 | 1991-09-20 | Novo Nordisk As | Heterocyclic compounds, their preparation and pharmaceutical preparations containing the compounds |
| ES2313714T3 (en) * | 1992-06-22 | 2009-03-01 | The Regents Of The University Of California | ANTIGONISTS OF GLYCINE RECEPTORS AND USE OF THE SAME. |
| DE4314592A1 (en) * | 1993-04-28 | 1994-11-03 | Schering Ag | Benzo (f) quinoxalinedione derivatives, their production and use in medicinal products |
| IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| DE4428152A1 (en) * | 1994-06-22 | 1996-01-04 | Basf Ag | New amido-quinoxalinediones, their production and use |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
| WO1996010023A1 (en) * | 1994-09-27 | 1996-04-04 | Yamanouchi Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroquinoxalindione derivative |
| DE4439493A1 (en) * | 1994-10-25 | 1996-05-02 | Schering Ag | New quinoxalinedione derivatives, their production and use in pharmaceuticals |
| DE4439492A1 (en) * | 1994-10-25 | 1996-05-02 | Schering Ag | New quinoxalinedione derivatives, their production and use in pharmaceuticals |
| US6110911A (en) * | 1995-06-07 | 2000-08-29 | Warner-Lambert Company | Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| DE19521058A1 (en) * | 1995-06-09 | 1996-12-12 | Basf Ag | Process for the preparation of aromatic-containing polyether polyols |
| DE19545251A1 (en) * | 1995-11-24 | 1997-05-28 | Schering Ag | New quinoxalinedione derivatives, their production and use in pharmaceuticals |
| TW448171B (en) * | 1996-06-06 | 2001-08-01 | Yamanouchi Pharma Co Ltd | Imidazole-substituted quinoxalinedione derivatives |
| DE19624808A1 (en) | 1996-06-21 | 1998-01-02 | Basf Ag | Pyrrolylquinoxalinediones, their preparation and use |
| DE19728326A1 (en) * | 1997-06-27 | 1999-01-07 | Schering Ag | New quinoxalinedione derivatives, their production and use in pharmaceuticals |
| US6015800A (en) * | 1997-09-03 | 2000-01-18 | Warner-Lambert Company | Substituted quinoxaline-2-ones as glutamate receptor antagonists |
| IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
| EP0900567A3 (en) * | 1997-09-05 | 2001-05-02 | Pfizer Products Inc. | Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy |
| FR2769309B1 (en) | 1997-10-08 | 2001-06-15 | Oreal | KERATINIC FIBER OXIDATION DYE COMPOSITION COMPRISING AN AMINO ACID DERIVATIVE AS AN OXIDATION BASE AND NOVEL AMINO ACID DERIVATIVES |
| GB0311406D0 (en) * | 2003-05-17 | 2003-06-25 | Queen Mary & Westfield College | Substituted phosphonate fluorescent sensors,and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0118982A1 (en) * | 1983-02-01 | 1984-09-19 | Sumitomo Chemical Company, Limited | Organic phosphorous quinoxalinone and their production and use |
| NO179551C (en) * | 1987-11-10 | 1996-10-30 | Novo Nordisk As | Analogous Process for Preparing Therapeutically Effective Quinoxaline Compounds |
| DK69790D0 (en) * | 1990-03-16 | 1990-03-16 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION OF USE |
-
1992
- 1992-10-23 PT PT101004A patent/PT101004B/en not_active IP Right Cessation
- 1992-10-25 PL PL92299929A patent/PL171125B1/en unknown
- 1992-10-25 SK SK727-93A patent/SK281518B6/en unknown
- 1992-10-25 WO PCT/DE1992/000895 patent/WO1993008173A1/en not_active Application Discontinuation
- 1992-10-25 EP EP92922676A patent/EP0565683A1/en not_active Withdrawn
- 1992-10-25 JP JP50735393A patent/JP3258008B2/en not_active Expired - Fee Related
- 1992-10-25 HU HU9301877A patent/HUT64756A/en unknown
- 1992-10-25 KR KR1019930701948A patent/KR100262371B1/en not_active IP Right Cessation
- 1992-10-25 AU AU28894/92A patent/AU664212B2/en not_active Ceased
- 1992-10-25 IL IL10353892A patent/IL103538A/en not_active IP Right Cessation
- 1992-10-25 RU RU93044489A patent/RU2117663C1/en active
- 1992-10-25 CA CA002099270A patent/CA2099270A1/en not_active Abandoned
- 1992-10-25 CZ CZ19931387A patent/CZ286351B6/en not_active IP Right Cessation
- 1992-10-26 CN CN92113338A patent/CN1038840C/en not_active Expired - Fee Related
- 1992-10-27 NZ NZ244896A patent/NZ244896A/en unknown
-
1993
- 1993-06-24 FI FI932959A patent/FI932959A/en unknown
- 1993-06-25 NO NO932116A patent/NO304693B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT101004A (en) | 1994-01-31 |
| AU664212B2 (en) | 1995-11-09 |
| CN1038840C (en) | 1998-06-24 |
| NO932344D0 (en) | 1993-06-25 |
| IL103538A0 (en) | 1993-03-15 |
| PT101004B (en) | 1999-10-29 |
| NZ244896A (en) | 1995-07-26 |
| CZ286351B6 (en) | 2000-03-15 |
| IL103538A (en) | 2001-07-24 |
| KR100262371B1 (en) | 2000-08-01 |
| NO932344L (en) | 1993-06-25 |
| RU2117663C1 (en) | 1998-08-20 |
| KR930703271A (en) | 1993-11-29 |
| PL299929A1 (en) | 1994-04-05 |
| CN1072929A (en) | 1993-06-09 |
| SK281518B6 (en) | 2001-04-09 |
| AU2889492A (en) | 1993-05-21 |
| JPH06503583A (en) | 1994-04-21 |
| NO304693B1 (en) | 1999-02-01 |
| FI932959A0 (en) | 1993-06-24 |
| PL171125B1 (en) | 1997-03-28 |
| HU9301877D0 (en) | 1993-09-28 |
| FI932959A (en) | 1993-06-24 |
| JP3258008B2 (en) | 2002-02-18 |
| WO1993008173A1 (en) | 1993-04-29 |
| SK72793A3 (en) | 1993-10-06 |
| EP0565683A1 (en) | 1993-10-20 |
| CZ138793A3 (en) | 1994-01-19 |
| CA2099270A1 (en) | 1993-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT64756A (en) | Process for the production of quinoxaline derivatives and of pharmaceutical compositions containing them | |
| HUT56565A (en) | Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same | |
| HUT63632A (en) | Process for producing 5-amino-4-hydroxyhexanoic acid derivatives and pharmaceutical compositions comprising same | |
| HUT63628A (en) | Process for producing new cefalosporing derivatives and pharmaceutical compositions comprising same | |
| HUT48619A (en) | Process for producing new heteroaromatic amine derivatives and pharmaceutical compositions comprising such compounds | |
| HUT59389A (en) | Process for producing heterocyclic compounds and pharmaceutical compositions comprising same | |
| HUT58303A (en) | Process for producing pyrimidinyl derivatives and pharmaceutical compositions containing them | |
| HUT54139A (en) | Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds | |
| PT86516A (en) | Process for the preparation of heteroaryl-3-oxo-propani-nitrile derivatives and of pharmaceutical compositions containing the same | |
| CZ95895A3 (en) | Novel taxan derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
| HUT48870A (en) | Process for producing aminoalkoxyphenyl derivatives and pharmaceutical compositions comprising same | |
| HUT56078A (en) | Process for producing piridazine derivatives and pharmaceutical compositions containing them | |
| HUT56342A (en) | Process for producing capsoicin derivatives and pharmaceutical compositions comprising such compounds | |
| HUT46644A (en) | Process for producing propylophenone derivatives and pharmaceutical compositions comprising the same | |
| HUT56373A (en) | Process for producing pyranobenzoxadiazole derivatives and pharmaceutical compositions comprising such compounds | |
| IL102362A0 (en) | 4-amino-3-hydroxycarboxylic acid derivatives,their production and pharmaceutical compositions containing them | |
| PT80824A (en) | Process for the preparation of phenylquinoline derivatives and of pharmaceutical compositions containing the same | |
| HUT61548A (en) | Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds | |
| HUT65768A (en) | 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them and process for the production thereof | |
| HUT65134A (en) | Process for the production of carbapenem-derivatives condensed with cyclohexan-ring and of pharmaceutical compositions containing it | |
| ZA848303B (en) | 1,2-dithiolan derivatives,process for their production,pharmaceutical compositions containing them and their use | |
| HU895817D0 (en) | Process for the preparation of phenyloxy-propanol-amine derivatives and pharmaceutical compositions containing them | |
| HU9400325D0 (en) | Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them | |
| HU901569D0 (en) | Process for the preparation of triazine derivatives and pharmaceutical compositions containing such compounds | |
| HUT63629A (en) | Process for producing substituted phenylquinazoline derivatives and pharmaceutical compositions comprising same |